Docking studies on novel analogues of 8 methoxy fluoroquinolones against GyrA mutants of Mycobacterium tuberculosis

BACKGROUND: Fluoroquinolone resistance is a serious threat in the battle against the treatment of multi drug resistant tuberculosis (MDR-TB) and extensively drug resistant tuberculosis (XDR-TB). Fluoroquinolone resistant isolates from India had shown to have evolved several mutants in the quinolone...

Descripción completa

Detalles Bibliográficos
Autores principales: Anand, RS, Somasundaram, Sulochana, Doble, Mukesh, Paramasivan, CN
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3298726/
https://www.ncbi.nlm.nih.gov/pubmed/22152119
http://dx.doi.org/10.1186/1472-6807-11-47

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3298726/
https://www.ncbi.nlm.nih.gov/pubmed/22152119
http://dx.doi.org/10.1186/1472-6807-11-47

Ejemplares similares